David Kauffmann
Medicine
MedTech Engine
Denmark
Biography
He is the founding managing partner of European Equity Partners, the chairman of CMC Biologics and ARTS Biologics. Until the merger with SGS in 2006, he also held the position of Chairman of the Management Board of Aster Cephac. Prior to EEP, from 1990, David Kauffmann was a partner of CAI, a North American US$150 million private equity investment fund. Prior to working in private equity and venturecapital, David Kauffmann worked for the American Express Bank in London, New York and Copenhagen, in acquisitions and trade finance. He is now the chairman of Azanta.
Research Interest
Medicine
